These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 19323898)

  • 21. GP IIb-IIIa inhibitors administered upstream: evidence for improved outcomes with conventional and newer antithrombotic agents?
    Tricoci P; Newby LK
    Cardiol Rev; 2008; 16(2):89-94. PubMed ID: 18281911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
    Rinaldi MJ; Kirtane AJ; Piana RN; Caputo RP; Gordon PC; Lopez JJ; Dauerman HL; Ryan TJ; Kiernan FJ; Cutlip DE; Ho KK; Gibson CM; Murphy SA; Cohen DJ
    Am Heart J; 2008 Apr; 155(4):654-60. PubMed ID: 18371472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-molecular-weight heparins and glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
    Ferguson J
    J Invasive Cardiol; 2004 Mar; 16(3):136-44. PubMed ID: 15152164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes.
    Rao RV; Goodman SG; Yan RT; Spencer FA; Fox KA; DeYoung JP; Rose B; Grondin FR; Gallo R; Gore JM; Yan AT;
    Am Heart J; 2009 Apr; 157(4):642-50.e1. PubMed ID: 19332190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The current state of antiplatelet therapy in acute coronary syndromes: the data and the real world.
    Alexander JH
    Cleve Clin J Med; 2009 Apr; 76 Suppl 1():S16-23. PubMed ID: 19332589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic drugs in vascular medicine: a historical perspective.
    Schrör K
    Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current antiplatelet therapies: benefits and limitations.
    Angiolillo DJ; Guzman LA; Bass TA
    Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.
    Chandra A; Glickman SW; Ou FS; Peacock WF; McCord JK; Cairns CB; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Ann Emerg Med; 2009 Jul; 54(1):17-25. PubMed ID: 19282062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet therapy in early management of non-ST-segment elevation acute coronary syndrome: the 2002 and 2007 guidelines from North America and Europe.
    Thomas D; Giugliano RP
    J Cardiovasc Pharmacol; 2008 May; 51(5):425-33. PubMed ID: 18418272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes.
    Yan AT; Yan RT; Tan M; Fung A; Cohen EA; Fitchett DH; Langer A; Goodman SG;
    Arch Intern Med; 2007 May; 167(10):1009-16. PubMed ID: 17533203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Underuse of antithrombotic and antiplatelet treatments for acute coronary syndrome in China: a note of caution.
    Cheng TO
    Chin Med J (Engl); 2009 May; 122(9):1120. PubMed ID: 19493455
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiplatelet therapy in older adults with non-ST-segment elevation acute coronary syndrome: considering risks and benefits.
    Lopes RD; Alexander KP
    Am J Cardiol; 2009 Sep; 104(5 Suppl):16C-21C. PubMed ID: 19695356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of the acute coronary syndrome in Germany: experiences in a German cluster of the GRACE registry].
    Tebbe U; Bramlage P; von Löwis of Menar P; Lawall H; Gaudron P; Lüders S; Klaus A; Lengfelder W; Scholz KH; Maziejewski S; Cuneo A; Hohmann V; Gulba D
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2000-5. PubMed ID: 17882737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antithrombotic therapy for non-ST segment elevation myocardial infarction].
    Hölschermann H
    Hamostaseologie; 2006 May; 26(2):106-13. PubMed ID: 16676052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal trends in antiplatelet/antithrombotic use in acute coronary syndromes and in-hospital major bleeding complications.
    Motivala AA; Tamhane U; Saab F; Li J; Rogers EK; Froehlich J; Moscucci M; Eagle KA; Gurm HS
    Am J Cardiol; 2007 Nov; 100(9):1359-63. PubMed ID: 17950790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of antithrombotics for acute coronary syndromes in the emergency department: considerations and impact.
    Mukherjee D; Eagle KA
    Prog Cardiovasc Dis; 2007; 50(3):167-80. PubMed ID: 17976502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
    Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
    Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tailored antithrombotic therapy for acute coronary syndromes.
    Fitchett D
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):935-44. PubMed ID: 18666844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [How to administer antithrombotic therapy in non-ST-elevation acute coronary syndromes: guidelines and clinical practice].
    Mafrici A
    Ital Heart J; 2005 May; 6 Suppl 3():24S-27S. PubMed ID: 15945316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.